| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cartilage, Articular | 49 | 2017 | 550 | 5.570 |
Why?
|
| Chondrocytes | 31 | 2017 | 208 | 4.470 |
Why?
|
| Bone Morphogenetic Proteins | 25 | 2009 | 105 | 3.740 |
Why?
|
| Transforming Growth Factor beta | 19 | 2008 | 124 | 2.710 |
Why?
|
| Osteoarthritis | 24 | 2017 | 384 | 2.570 |
Why?
|
| Bone Morphogenetic Protein 7 | 27 | 2016 | 63 | 2.480 |
Why?
|
| Insulin-Like Growth Factor I | 8 | 2017 | 69 | 1.400 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 4 | 2016 | 60 | 1.150 |
Why?
|
| Cytokines | 6 | 2017 | 351 | 1.070 |
Why?
|
| Cartilage | 12 | 2016 | 159 | 0.960 |
Why?
|
| Fractures, Cartilage | 2 | 2015 | 5 | 0.890 |
Why?
|
| Cells, Cultured | 23 | 2017 | 686 | 0.870 |
Why?
|
| Synovial Fluid | 4 | 2017 | 127 | 0.840 |
Why?
|
| Regeneration | 2 | 2016 | 27 | 0.830 |
Why?
|
| Cell Survival | 6 | 2017 | 164 | 0.750 |
Why?
|
| Ankle Joint | 4 | 2010 | 42 | 0.720 |
Why?
|
| Extracellular Matrix | 9 | 2009 | 75 | 0.640 |
Why?
|
| Gene Expression Regulation | 5 | 2017 | 286 | 0.630 |
Why?
|
| Intervertebral Disc | 4 | 2007 | 218 | 0.610 |
Why?
|
| Interleukin-1 | 6 | 2003 | 79 | 0.610 |
Why?
|
| Humans | 60 | 2017 | 31073 | 0.610 |
Why?
|
| Proteoglycans | 11 | 2017 | 345 | 0.590 |
Why?
|
| Aging | 5 | 2016 | 1729 | 0.580 |
Why?
|
| Tissue Engineering | 5 | 2016 | 39 | 0.570 |
Why?
|
| Osteoarthritis, Knee | 5 | 2016 | 400 | 0.560 |
Why?
|
| Ankle Injuries | 3 | 2016 | 13 | 0.560 |
Why?
|
| Orthopedics | 2 | 2016 | 128 | 0.540 |
Why?
|
| Interleukin-1beta | 4 | 2009 | 61 | 0.540 |
Why?
|
| Transplantation, Homologous | 2 | 2017 | 296 | 0.540 |
Why?
|
| Allografts | 2 | 2017 | 202 | 0.530 |
Why?
|
| RNA, Messenger | 15 | 2006 | 329 | 0.520 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2016 | 35 | 0.520 |
Why?
|
| Intervertebral Disc Displacement | 2 | 2007 | 131 | 0.510 |
Why?
|
| Animals | 32 | 2017 | 4720 | 0.510 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2012 | 365 | 0.510 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 103 | 0.490 |
Why?
|
| Metalloendopeptidases | 8 | 2004 | 25 | 0.490 |
Why?
|
| Oxidative Stress | 2 | 2016 | 134 | 0.480 |
Why?
|
| Platelet-Rich Plasma | 1 | 2016 | 86 | 0.480 |
Why?
|
| Apoptosis | 3 | 2013 | 260 | 0.480 |
Why?
|
| Proteins | 2 | 2005 | 73 | 0.440 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2011 | 135 | 0.430 |
Why?
|
| Middle Aged | 28 | 2017 | 10240 | 0.390 |
Why?
|
| Wound Healing | 4 | 2015 | 174 | 0.390 |
Why?
|
| Adult | 23 | 2017 | 8950 | 0.370 |
Why?
|
| Poloxamer | 1 | 2010 | 4 | 0.370 |
Why?
|
| Surface-Active Agents | 1 | 2010 | 7 | 0.370 |
Why?
|
| MAP Kinase Signaling System | 2 | 2017 | 38 | 0.360 |
Why?
|
| Male | 30 | 2017 | 16499 | 0.350 |
Why?
|
| Immunohistochemistry | 12 | 2015 | 430 | 0.340 |
Why?
|
| Matrix Metalloproteinases | 3 | 2017 | 23 | 0.330 |
Why?
|
| Knee Joint | 6 | 2015 | 827 | 0.330 |
Why?
|
| Aged | 23 | 2017 | 10082 | 0.320 |
Why?
|
| Keratan Sulfate | 2 | 2006 | 27 | 0.320 |
Why?
|
| Membrane Proteins | 2 | 2001 | 184 | 0.320 |
Why?
|
| Aggrecans | 8 | 2017 | 157 | 0.320 |
Why?
|
| Extracellular Matrix Proteins | 4 | 2006 | 131 | 0.320 |
Why?
|
| Rabbits | 9 | 2015 | 286 | 0.310 |
Why?
|
| Homeostasis | 2 | 2007 | 86 | 0.310 |
Why?
|
| Interleukin-6 | 3 | 2014 | 112 | 0.310 |
Why?
|
| Bioartificial Organs | 2 | 2005 | 2 | 0.310 |
Why?
|
| DNA Methylation | 1 | 2008 | 132 | 0.290 |
Why?
|
| Biomarkers | 1 | 2011 | 734 | 0.290 |
Why?
|
| Aged, 80 and over | 12 | 2010 | 5197 | 0.280 |
Why?
|
| Activin Receptors, Type I | 2 | 2005 | 3 | 0.270 |
Why?
|
| Blotting, Western | 7 | 2003 | 178 | 0.270 |
Why?
|
| Collagenases | 5 | 2003 | 21 | 0.260 |
Why?
|
| Cell Differentiation | 3 | 2003 | 152 | 0.260 |
Why?
|
| In Situ Hybridization | 8 | 2004 | 52 | 0.260 |
Why?
|
| Rotator Cuff | 3 | 2015 | 283 | 0.260 |
Why?
|
| Fingers | 2 | 2005 | 12 | 0.250 |
Why?
|
| Hyaluronic Acid | 1 | 2006 | 102 | 0.250 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2005 | 13 | 0.250 |
Why?
|
| Osteoblasts | 1 | 2004 | 63 | 0.230 |
Why?
|
| Up-Regulation | 4 | 2003 | 177 | 0.230 |
Why?
|
| Stress, Mechanical | 3 | 2015 | 173 | 0.220 |
Why?
|
| Receptors, Growth Factor | 1 | 2002 | 4 | 0.210 |
Why?
|
| Activin Receptors, Type II | 1 | 2002 | 2 | 0.210 |
Why?
|
| Female | 19 | 2014 | 17017 | 0.210 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 158 | 0.210 |
Why?
|
| Alginates | 3 | 2008 | 10 | 0.210 |
Why?
|
| Rats | 5 | 2007 | 871 | 0.210 |
Why?
|
| Finger Phalanges | 2 | 2016 | 4 | 0.200 |
Why?
|
| Osteoporosis | 1 | 2003 | 85 | 0.190 |
Why?
|
| Gene Expression | 4 | 2009 | 239 | 0.190 |
Why?
|
| Nasal Mucosa | 1 | 2001 | 17 | 0.190 |
Why?
|
| Disease Models, Animal | 4 | 2009 | 782 | 0.190 |
Why?
|
| Tendon Injuries | 2 | 2015 | 205 | 0.180 |
Why?
|
| Rotator Cuff Injuries | 3 | 2010 | 298 | 0.180 |
Why?
|
| Bupivacaine | 2 | 2012 | 57 | 0.180 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2013 | 234 | 0.180 |
Why?
|
| Cattle | 7 | 2014 | 220 | 0.170 |
Why?
|
| Mice | 7 | 2016 | 1681 | 0.170 |
Why?
|
| Signal Transduction | 4 | 2016 | 498 | 0.170 |
Why?
|
| Anesthetics, Local | 2 | 2012 | 97 | 0.170 |
Why?
|
| Pain | 3 | 2016 | 426 | 0.170 |
Why?
|
| Femur | 4 | 2017 | 402 | 0.160 |
Why?
|
| Gene Expression Profiling | 3 | 2011 | 165 | 0.160 |
Why?
|
| Tendons | 4 | 2015 | 229 | 0.150 |
Why?
|
| Biomimetic Materials | 2 | 2009 | 8 | 0.150 |
Why?
|
| Periosteum | 2 | 2016 | 6 | 0.150 |
Why?
|
| Drug Synergism | 2 | 2008 | 66 | 0.150 |
Why?
|
| History, 20th Century | 2 | 2016 | 70 | 0.150 |
Why?
|
| Wnt-5a Protein | 1 | 2017 | 1 | 0.150 |
Why?
|
| Palmitic Acid | 1 | 2017 | 5 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2007 | 467 | 0.150 |
Why?
|
| Diet, High-Fat | 1 | 2017 | 18 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 7 | 2004 | 166 | 0.150 |
Why?
|
| Phosphorylation | 3 | 2017 | 163 | 0.140 |
Why?
|
| Sterilization | 2 | 2014 | 10 | 0.140 |
Why?
|
| Connective Tissue | 1 | 2016 | 26 | 0.140 |
Why?
|
| Interleukins | 1 | 2017 | 38 | 0.140 |
Why?
|
| History, 21st Century | 1 | 2016 | 35 | 0.140 |
Why?
|
| Glucuronic Acid | 2 | 2008 | 9 | 0.140 |
Why?
|
| Hexuronic Acids | 2 | 2008 | 10 | 0.140 |
Why?
|
| Proteome | 1 | 2016 | 44 | 0.140 |
Why?
|
| Models, Animal | 4 | 2015 | 130 | 0.140 |
Why?
|
| Early Medical Intervention | 1 | 2016 | 16 | 0.130 |
Why?
|
| Cell Culture Techniques | 2 | 2008 | 45 | 0.130 |
Why?
|
| Recombinant Proteins | 4 | 2017 | 256 | 0.130 |
Why?
|
| Metabolism | 2 | 2017 | 9 | 0.130 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 36 | 0.130 |
Why?
|
| Tissue Culture Techniques | 3 | 2016 | 11 | 0.130 |
Why?
|
| Homeodomain Proteins | 1 | 2016 | 61 | 0.130 |
Why?
|
| Capsaicin | 1 | 2015 | 11 | 0.130 |
Why?
|
| Adipose Tissue | 1 | 2016 | 78 | 0.130 |
Why?
|
| Child, Preschool | 4 | 2016 | 691 | 0.130 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 2015 | 5 | 0.130 |
Why?
|
| Mitochondria | 1 | 2016 | 87 | 0.130 |
Why?
|
| Matrix Metalloproteinase 13 | 4 | 2015 | 32 | 0.130 |
Why?
|
| Chondrogenesis | 1 | 2015 | 31 | 0.130 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2015 | 48 | 0.120 |
Why?
|
| Arthroplasty, Subchondral | 1 | 2015 | 28 | 0.120 |
Why?
|
| Lectins, C-Type | 3 | 2005 | 111 | 0.120 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2015 | 35 | 0.120 |
Why?
|
| Time Factors | 3 | 2009 | 1680 | 0.120 |
Why?
|
| Infant, Newborn | 4 | 2001 | 637 | 0.120 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 387 | 0.120 |
Why?
|
| Biomechanical Phenomena | 4 | 2015 | 700 | 0.120 |
Why?
|
| Dexamethasone | 1 | 2014 | 48 | 0.120 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2014 | 4 | 0.120 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2014 | 5 | 0.120 |
Why?
|
| Antibodies, Antinuclear | 1 | 2014 | 21 | 0.120 |
Why?
|
| Glucocorticoids | 1 | 2014 | 71 | 0.120 |
Why?
|
| Interleukin-10 | 1 | 2014 | 39 | 0.120 |
Why?
|
| Osteotomy | 1 | 2015 | 171 | 0.120 |
Why?
|
| Menisci, Tibial | 2 | 2014 | 187 | 0.110 |
Why?
|
| Shoulder | 1 | 2015 | 167 | 0.110 |
Why?
|
| Interferon-alpha | 1 | 2014 | 69 | 0.110 |
Why?
|
| Inflammation | 1 | 2016 | 361 | 0.110 |
Why?
|
| Antibody Specificity | 3 | 2002 | 54 | 0.110 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2014 | 53 | 0.110 |
Why?
|
| Chlorhexidine | 1 | 2014 | 61 | 0.110 |
Why?
|
| Mice, Nude | 3 | 2016 | 36 | 0.110 |
Why?
|
| Joints | 2 | 2011 | 99 | 0.110 |
Why?
|
| Bacterial Secretion Systems | 1 | 2013 | 2 | 0.110 |
Why?
|
| Disease Progression | 1 | 2016 | 833 | 0.110 |
Why?
|
| Endopeptidases | 3 | 2013 | 30 | 0.110 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2012 | 25 | 0.100 |
Why?
|
| Anti-Infective Agents | 1 | 2013 | 63 | 0.100 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2013 | 79 | 0.100 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2012 | 34 | 0.100 |
Why?
|
| Immunity, Innate | 1 | 2013 | 97 | 0.100 |
Why?
|
| Matrix Metalloproteinase 8 | 4 | 2001 | 7 | 0.100 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2012 | 42 | 0.100 |
Why?
|
| Synovial Membrane | 1 | 2012 | 84 | 0.100 |
Why?
|
| Transplantation, Autologous | 2 | 2012 | 198 | 0.100 |
Why?
|
| ADAM Proteins | 3 | 2004 | 66 | 0.100 |
Why?
|
| Adolescent | 4 | 2016 | 2403 | 0.100 |
Why?
|
| Collagen | 3 | 2003 | 104 | 0.100 |
Why?
|
| Osseointegration | 1 | 2012 | 77 | 0.100 |
Why?
|
| Young Adult | 3 | 2017 | 2061 | 0.100 |
Why?
|
| Smad1 Protein | 2 | 2009 | 3 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 59 | 0.090 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2014 | 221 | 0.090 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2008 | 21 | 0.090 |
Why?
|
| Wounds and Injuries | 1 | 2011 | 43 | 0.090 |
Why?
|
| Substance P | 2 | 2008 | 18 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 2 | 2008 | 81 | 0.090 |
Why?
|
| Matrix Metalloproteinase 3 | 3 | 2001 | 11 | 0.090 |
Why?
|
| Talus | 1 | 2010 | 12 | 0.090 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2010 | 12 | 0.090 |
Why?
|
| Tail | 2 | 2007 | 4 | 0.090 |
Why?
|
| Pyridines | 1 | 2010 | 47 | 0.090 |
Why?
|
| Cell Death | 2 | 2009 | 61 | 0.090 |
Why?
|
| Tissue Donors | 1 | 2011 | 81 | 0.090 |
Why?
|
| ADAM10 Protein | 2 | 2001 | 5 | 0.090 |
Why?
|
| Amyloid Precursor Protein Secretases | 2 | 2001 | 17 | 0.090 |
Why?
|
| Models, Biological | 2 | 2009 | 346 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 144 | 0.090 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2009 | 5 | 0.090 |
Why?
|
| Imidazoles | 1 | 2010 | 73 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 444 | 0.090 |
Why?
|
| Fibronectins | 2 | 2015 | 33 | 0.090 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2012 | 281 | 0.090 |
Why?
|
| Hyperalgesia | 2 | 2007 | 52 | 0.080 |
Why?
|
| Base Sequence | 3 | 1999 | 134 | 0.080 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 370 | 0.080 |
Why?
|
| Bone Morphogenetic Protein Receptors | 1 | 2009 | 1 | 0.080 |
Why?
|
| Smad4 Protein | 1 | 2009 | 2 | 0.080 |
Why?
|
| Smad6 Protein | 1 | 2009 | 3 | 0.080 |
Why?
|
| Finger Joint | 2 | 2005 | 8 | 0.080 |
Why?
|
| Growth Differentiation Factor 5 | 1 | 2008 | 8 | 0.080 |
Why?
|
| Azacitidine | 1 | 2008 | 12 | 0.080 |
Why?
|
| Child | 3 | 2016 | 1431 | 0.080 |
Why?
|
| Athletic Injuries | 1 | 2010 | 180 | 0.080 |
Why?
|
| Anterior Cruciate Ligament Reconstruction | 1 | 2012 | 245 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2009 | 204 | 0.080 |
Why?
|
| Annexin A5 | 2 | 1999 | 2 | 0.080 |
Why?
|
| Culture Techniques | 2 | 1999 | 24 | 0.080 |
Why?
|
| Shoulder Pain | 1 | 2008 | 61 | 0.080 |
Why?
|
| Amino Acid Sequence | 3 | 2016 | 195 | 0.080 |
Why?
|
| Tendinopathy | 1 | 2008 | 61 | 0.080 |
Why?
|
| Collagen Type II | 3 | 2015 | 33 | 0.070 |
Why?
|
| Physical Stimulation | 1 | 2007 | 12 | 0.070 |
Why?
|
| Shoulder Joint | 2 | 2015 | 606 | 0.070 |
Why?
|
| Injections, Epidural | 1 | 2007 | 17 | 0.070 |
Why?
|
| Pain Threshold | 1 | 2007 | 22 | 0.070 |
Why?
|
| Spinal Nerve Roots | 1 | 2007 | 29 | 0.070 |
Why?
|
| Infant | 2 | 2000 | 577 | 0.070 |
Why?
|
| Cell Division | 2 | 2005 | 113 | 0.070 |
Why?
|
| Dogs | 1 | 2007 | 264 | 0.070 |
Why?
|
| Orthopedic Procedures | 1 | 2010 | 329 | 0.070 |
Why?
|
| Ossification, Heterotopic | 1 | 2007 | 41 | 0.070 |
Why?
|
| Antibodies | 1 | 2007 | 67 | 0.070 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2006 | 14 | 0.070 |
Why?
|
| High Mobility Group Proteins | 1 | 2006 | 3 | 0.070 |
Why?
|
| Growth Substances | 1 | 2006 | 39 | 0.070 |
Why?
|
| DNA | 2 | 2003 | 124 | 0.070 |
Why?
|
| Joint Capsule | 1 | 2006 | 46 | 0.070 |
Why?
|
| Swine | 2 | 2004 | 92 | 0.070 |
Why?
|
| Smad5 Protein | 1 | 2006 | 2 | 0.070 |
Why?
|
| Knee Injuries | 1 | 2009 | 238 | 0.070 |
Why?
|
| Autoantigens | 1 | 2006 | 39 | 0.070 |
Why?
|
| Phosphoproteins | 1 | 2006 | 30 | 0.070 |
Why?
|
| Bursa, Synovial | 1 | 2006 | 10 | 0.070 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2005 | 22 | 0.070 |
Why?
|
| Lacerations | 1 | 2006 | 18 | 0.070 |
Why?
|
| Reference Values | 1 | 2006 | 230 | 0.060 |
Why?
|
| In Vitro Techniques | 2 | 2016 | 215 | 0.060 |
Why?
|
| Autopsy | 2 | 2006 | 352 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2006 | 172 | 0.060 |
Why?
|
| Bioprosthesis | 1 | 2005 | 10 | 0.060 |
Why?
|
| Artificial Limbs | 1 | 2005 | 7 | 0.060 |
Why?
|
| Behavior, Animal | 1 | 2005 | 105 | 0.060 |
Why?
|
| Doxycycline | 2 | 1994 | 20 | 0.060 |
Why?
|
| Implants, Experimental | 1 | 2004 | 32 | 0.060 |
Why?
|
| Anabolic Agents | 1 | 2004 | 6 | 0.060 |
Why?
|
| Motor Activity | 1 | 2007 | 370 | 0.060 |
Why?
|
| Cell Membrane | 2 | 2001 | 106 | 0.060 |
Why?
|
| Spinal Diseases | 1 | 2005 | 155 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 2006 | 107 | 0.050 |
Why?
|
| Tissue Extracts | 1 | 2002 | 12 | 0.050 |
Why?
|
| Culture Media | 1 | 2002 | 35 | 0.050 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2002 | 1 | 0.050 |
Why?
|
| Osteogenesis | 1 | 2003 | 107 | 0.050 |
Why?
|
| Protein Precursors | 1 | 2002 | 20 | 0.050 |
Why?
|
| Procollagen | 1 | 2001 | 8 | 0.050 |
Why?
|
| Lumbar Vertebrae | 1 | 2007 | 523 | 0.050 |
Why?
|
| Pressure | 2 | 2015 | 64 | 0.050 |
Why?
|
| Chondrosarcoma | 2 | 1997 | 37 | 0.040 |
Why?
|
| Transfection | 2 | 2015 | 127 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2001 | 271 | 0.040 |
Why?
|
| Oligonucleotide Probes | 1 | 1999 | 6 | 0.040 |
Why?
|
| Peptide Fragments | 2 | 2016 | 98 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 1997 | 247 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2013 | 113 | 0.040 |
Why?
|
| Phenazines | 1 | 1998 | 5 | 0.040 |
Why?
|
| Coloring Agents | 1 | 1998 | 13 | 0.040 |
Why?
|
| Podiatry | 1 | 1997 | 1 | 0.040 |
Why?
|
| Metatarsophalangeal Joint | 1 | 1997 | 5 | 0.040 |
Why?
|
| Awards and Prizes | 1 | 1997 | 24 | 0.040 |
Why?
|
| Oleic Acid | 1 | 2017 | 1 | 0.040 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2017 | 7 | 0.040 |
Why?
|
| Matrix Metalloproteinases, Secreted | 1 | 2016 | 1 | 0.040 |
Why?
|
| Fibrillar Collagens | 1 | 2016 | 2 | 0.040 |
Why?
|
| Glycosaminoglycans | 2 | 2013 | 53 | 0.040 |
Why?
|
| Proteolysis | 1 | 2016 | 13 | 0.040 |
Why?
|
| Friction | 1 | 2016 | 20 | 0.040 |
Why?
|
| Wnt Signaling Pathway | 1 | 2017 | 32 | 0.030 |
Why?
|
| Kinetics | 1 | 2016 | 228 | 0.030 |
Why?
|
| Heterografts | 1 | 2016 | 14 | 0.030 |
Why?
|
| Vitamin K 3 | 1 | 2016 | 2 | 0.030 |
Why?
|
| Catalase | 1 | 2016 | 7 | 0.030 |
Why?
|
| Transgenes | 1 | 2016 | 16 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2016 | 21 | 0.030 |
Why?
|
| Cellular Senescence | 1 | 2016 | 19 | 0.030 |
Why?
|
| Proteomics | 1 | 2016 | 96 | 0.030 |
Why?
|
| Collagen Type III | 1 | 2015 | 14 | 0.030 |
Why?
|
| Meniscus | 1 | 2016 | 21 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 463 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2015 | 22 | 0.030 |
Why?
|
| Tissue Scaffolds | 1 | 2015 | 24 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 54 | 0.030 |
Why?
|
| Neutrophils | 1 | 1996 | 120 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 132 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 52 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 260 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2015 | 81 | 0.030 |
Why?
|
| Interleukin-1alpha | 1 | 2014 | 4 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2008 | 534 | 0.030 |
Why?
|
| Cadaver | 2 | 2010 | 380 | 0.030 |
Why?
|
| Culture Media, Conditioned | 3 | 2003 | 31 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 230 | 0.030 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2013 | 6 | 0.030 |
Why?
|
| Tibia | 3 | 2006 | 274 | 0.030 |
Why?
|
| Blotting, Northern | 3 | 1997 | 27 | 0.030 |
Why?
|
| Colony Count, Microbial | 1 | 2013 | 24 | 0.030 |
Why?
|
| Tibial Meniscus Injuries | 1 | 2014 | 98 | 0.030 |
Why?
|
| Lipopeptides | 1 | 2012 | 12 | 0.030 |
Why?
|
| Gamma Rays | 1 | 2012 | 16 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 133 | 0.020 |
Why?
|
| Pain, Postoperative | 1 | 2015 | 334 | 0.020 |
Why?
|
| DNA Primers | 2 | 2004 | 53 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 1006 | 0.020 |
Why?
|
| RNA | 2 | 2003 | 38 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 143 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2011 | 80 | 0.020 |
Why?
|
| Elastic Modulus | 1 | 2009 | 12 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 326 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2010 | 301 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2010 | 78 | 0.020 |
Why?
|
| Suture Techniques | 1 | 2010 | 145 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2009 | 43 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2009 | 16 | 0.020 |
Why?
|
| Hindlimb | 1 | 2009 | 25 | 0.020 |
Why?
|
| Injections, Intra-Articular | 1 | 2009 | 97 | 0.020 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2008 | 15 | 0.020 |
Why?
|
| Axons | 1 | 2008 | 37 | 0.020 |
Why?
|
| Random Allocation | 1 | 2008 | 147 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2009 | 222 | 0.020 |
Why?
|
| Chickens | 2 | 1999 | 32 | 0.020 |
Why?
|
| Rupture | 1 | 2008 | 121 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 1318 | 0.020 |
Why?
|
| Arthritis, Experimental | 1 | 2009 | 132 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 1997 | 149 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 2010 | 737 | 0.020 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 2006 | 3 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2006 | 19 | 0.020 |
Why?
|
| SOX9 Transcription Factor | 1 | 2006 | 14 | 0.020 |
Why?
|
| Microscopy, Atomic Force | 1 | 2006 | 9 | 0.020 |
Why?
|
| Bone Remodeling | 1 | 2006 | 46 | 0.020 |
Why?
|
| Nanostructures | 1 | 2006 | 13 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2006 | 60 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2006 | 63 | 0.020 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2006 | 1 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2006 | 18 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2006 | 2 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2006 | 26 | 0.020 |
Why?
|
| Polyglycolic Acid | 1 | 2005 | 2 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2005 | 62 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2005 | 17 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2005 | 23 | 0.020 |
Why?
|
| Polymers | 1 | 2005 | 42 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2006 | 47 | 0.020 |
Why?
|
| Injections, Spinal | 1 | 2005 | 53 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2005 | 54 | 0.020 |
Why?
|
| Cell Line | 1 | 2006 | 305 | 0.020 |
Why?
|
| Chick Embryo | 2 | 1994 | 20 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2005 | 126 | 0.020 |
Why?
|
| Taq Polymerase | 1 | 2004 | 2 | 0.010 |
Why?
|
| DNA Probes | 1 | 2004 | 9 | 0.010 |
Why?
|
| Smad Proteins | 1 | 2004 | 6 | 0.010 |
Why?
|
| ADAMTS4 Protein | 1 | 2004 | 19 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2004 | 28 | 0.010 |
Why?
|
| Procollagen N-Endopeptidase | 1 | 2004 | 16 | 0.010 |
Why?
|
| Luciferases | 1 | 2003 | 24 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2003 | 43 | 0.010 |
Why?
|
| Plasmids | 1 | 2003 | 45 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2003 | 38 | 0.010 |
Why?
|
| Temperature | 1 | 2003 | 75 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 274 | 0.010 |
Why?
|
| Fetus | 1 | 1999 | 59 | 0.010 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 1997 | 7 | 0.010 |
Why?
|
| Tretinoin | 1 | 1997 | 15 | 0.010 |
Why?
|
| Matrix Metalloproteinases, Membrane-Associated | 1 | 1997 | 6 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1997 | 38 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 1997 | 80 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 1997 | 120 | 0.010 |
Why?
|
| Hydroxyproline | 1 | 1994 | 7 | 0.010 |
Why?
|
| Gelatinases | 1 | 1994 | 3 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1994 | 8 | 0.010 |
Why?
|
| Age Factors | 1 | 1997 | 875 | 0.010 |
Why?
|
| United States | 1 | 1997 | 2376 | 0.010 |
Why?
|